Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: A flag for non-HDL-C

Atherosclerosis

Volumn 230, Issue 1, 2013, Pages 106-109

  Zambon, Alberto ^a   Puato, Massimo ^a   Faggin, Elisabetta ^a   Grego, Franco ^b   Rattazzi, Marcello ^c   Pauletto, Paolo ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b Thoracic and Vascular Sciences ^*  (Italy)

^c OSPEDALE CA FONCELLO   (Italy)

Author keywords

Carotid plaque; Inflammation; LDL density; Lipoprotein remnants; Macrophages; Non HDL C

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCLONAL ANTIBODY; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOCYTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MALE; PREVALENCE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

CAROTID PLAQUE; INFLAMMATION; LDL DENSITY; LIPOPROTEIN REMNANTS; MACROPHAGES; NON-HDL-C;

AGED; ANTIBODIES, MONOCLONAL; CAROTID STENOSIS; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPOPROTEINS; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; TEMPERATURE; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 84881655947     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.06.024     Document Type: Article

References (16)

1. Faggin E., Zambon A., Puato M., Deeb S.S., Bertocco S., Sartore S., et al. Association between the --514 c-t polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis. JAm Coll Cardiol 2002, 40:1059-1066.
2. Spagnoli L.G., Mauriello A., Sangiorgi G., Fratoni S., Bonanno E., Schwartz R.S., et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAm Med Assoc 2004, 292:1845-1852.
3. Amarenco P., Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009, 8:453-463.
4. Puato M., Zambon A., Faggin E., Rattazzi M., Pauletto P. Statin treatment and carotid plaque composition. Review of clinical studies. Curr Vasc Pharmacol 2012, [published online ahead of print October 17, 2012].
5. Bishop B.M. Systematic review of CETP inhibitors for increasing high-density lipoprotein cholesterol: where do these agents stand in the approval process?. Am J Ther 2013.
6. Voight B.F., Peloso G.M., Orho-Melander M., Frikke-Schmidt R., Barbalic M., Jensen M.K., et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012, 380:572-580.
7. Puato M., Faggin E., Rattazzi M., Zambon A., Cipollone F., Grego F., et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy. Stroke 2010, 41:1163-1168.
8. Zambon A., Puato M., Faggin E., Bertocco S., Vitturi N., Polentarutti V., et al. Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: impact of plaque composition and lipoprotein phenotype. Atherosclerosis 2006, 185:121-126.
9. Pauletto P., Puato M., Faggin E., Santipolo N., Pagliara V., Zoleo M., et al. Specific cellular features of atheroma associated with development of neointima after carotid endarterectomy: the carotid atherosclerosis and restenosis study. Circulation 2000, 102:771-778.
10. Capell W.H., Zambon A., Austin M.A., Brunzell J.D., Hokanson J.E. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype a and LDL subclass phenotype b. Arterioscler Thromb Vasc Biol 1996, 16:1040-1046.
11. Lewington S., Whitlock G., Clarke R., Sherliker P., Emberson J., Halsey J., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839.
12. Chait A., Brazg R.L., Tribble D.L., Krauss R.M. Susceptibility of small, dense low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993, 94:350-356.
13. Hurt-Camejo E., Olsson U., Wiklund O., Bondjers G., Camejo G. Cellular consequences of the association of apo B lipoproteins with proteoglycans. Potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol 1997, 17(6):1011-1017.
14. Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R., Wiklund O., et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the european society of cardiology (ESC) and the european atherosclerosis society (EAS). Eur Heart J 2011, 32:1769-1818.
15. Boekholdt S.M., Arsenault B.J., Mora S., Pedersen T.R., LaRosa J.C., Nestel P.J., et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins. JAm Med Assoc 2012, 307(12):1302-1309.
16. Norata G.D., Raselli S., Grigore L., Garlaschelli K., Vianello D., Bertocco S., et al. Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells. Atherosclerosis 2009, 206:556-562.